Quantum Computing Inc. (QUBT) entered the second quarter of 2026 with a clear mandate to transition from a technology developer into a full-scale commercial quantum manufacturing company.
The shift follows the company’s strategic acquisitions of Luminar Semiconductor and NuCrypt, which repositioned QCi as a more operationally driven enterprise with tangible manufacturing ambitions.
QCi closed the first quarter carrying a contract backlog of approximately $16 million alongside a strong cash position, providing a financial runway to pursue its commercial objectives.
Throughout Q2, the company was expected to focus on executing existing contracts while simultaneously pursuing new opportunities across both commercial and government sectors.
One of the most closely watched near-term product milestones involves QCi’s next-generation Dirac optimization machine, which entered internal testing during the second quarter with engineers reporting encouraging technical results on a consistent basis.
The company’s Fab 1 thin-film lithium niobate foundry located in Arizona was expected to continue ramping up small-batch manufacturing capabilities, with improved foundry revenues driven by prototype chip fabrication.
A central strategic objective for Q2 was advancing Fab 2, QCi’s proposed large-scale manufacturing facility, which the company views as the foundation for producing quantum hardware at commercial scale over the long term.
On the competitive front, Rigetti Computing (RGTI) remains on track to deliver a 150-plus-qubit system with approximately 99.7% median two-qubit fidelity by the end of 2026, supported by its chiplet architecture and existing Fab 1 facility.
D-Wave Quantum Inc. (QBTS) announced a forthcoming gate-model quantum computing simulator described as the first of its kind designed for error-aware programming, while continuing to advance its Advantage2 annealing platform and Leap cloud service.
Despite its commercial ambitions, QUBT shares have fallen 21.6% over the past year, compared to a 4.6% decline for the broader industry, reflecting persistent investor skepticism.
Valuation remains a significant concern, with QUBT trading at a forward 12-month price-to-sales ratio of 65.33X, far above the industry median of 4.72X, suggesting the stock carries substantial premium risk.
Analyst loss-per-share estimates for QUBT in 2026 have held steady at 14 cents over the past 30 days, indicating little shift in near-term earnings expectations from the analyst community.
QUBT currently holds a Zacks Rank of 3, designated as a Hold, reflecting a cautious but not bearish outlook as the company works to prove its commercial strategy can deliver tangible results.
